Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Skip to content

Polyethylene glycol-superoxide dismutase inhibits lipid peroxidation in hepatic ischemia/reperfusion injury

Metadata Updated: September 6, 2025

Background: Hepatic injury after ischemia/reperfusion is attributed to the development of oxygen free radical (OFR)-mediated lipid peroxidation - a process that can be measured through its byproducts, specifically malondialdehyde. The use of free radical scavengers can offer significant protection against OFR-induced liver injury. We hypothesize that a new potent OFR scavenger, polyethylene glycol-superoxide dismutase (PEG-SOD), can inhibit OFR-mediated lipid peroxidation in hepatic ischemia/reperfusion injury.

      Methods:
      Twelve male Sprague-Dawley rats (300-350 g) were subjected to
            occlusion of the left and middle hepatic arteries and portal veins for 90 min,
            followed by 120 min reperfusion. PEG-SOD (5000 units/kg) was given intravenously
            before vascular occlusion and again immediately upon reperfusion to six rats.
            Normal saline was given to the remaining six rats to be used as a control
            group. The right hepatic lobe (used as internal control) and left hepatic lobe
            were harvested separately and tissue malondialdehyde was measured.


      Results:
      A marked increase in lipid peroxide was found in the normal saline
            group after 2 h reperfusion. Treatment with PEG-SOD prevented the rise in tissue
            malondialdehyde. The mean difference in the malondialdehyde between the left
            and right hepatic lobes were 13.20 ± 6.35 and 1.70 ± 3.65 nmol/g in the
            normal saline (control) and PEG-SOD groups, respectively. This difference was
            found to be statistically significant (P < 0.005) using
            Student's t-test.


      Conclusions:
      PEG-SOD can effectively attenuate hepatic ischemia/reperfusion
            injury by inhibiting OFR-mediated lipid peroxidation.

Access & Use Information

Public: This dataset is intended for public access and use. License: No license information was provided. If this work was prepared by an officer or employee of the United States government as part of that person's official duties it is considered a U.S. Government Work.

Downloads & Resources

Dates

Metadata Created Date July 24, 2025
Metadata Updated Date September 6, 2025

Metadata Source

Harvested from Healthdata.gov

Additional Metadata

Resource Type Dataset
Metadata Created Date July 24, 2025
Metadata Updated Date September 6, 2025
Publisher National Institutes of Health
Maintainer
NIH
Identifier https://healthdata.gov/api/views/2fab-r5gs
Data First Published 2025-07-13
Data Last Modified 2025-09-06
Category NIH
Public Access Level public
Bureau Code 009:25
Metadata Context https://project-open-data.cio.gov/v1.1/schema/catalog.jsonld
Metadata Catalog ID https://healthdata.gov/data.json
Schema Version https://project-open-data.cio.gov/v1.1/schema
Catalog Describedby https://project-open-data.cio.gov/v1.1/schema/catalog.json
Harvest Object Id 923af7a8-384a-4742-9ee2-365a10336087
Harvest Source Id 651e43b2-321c-4e4c-b86a-835cfc342cb0
Harvest Source Title Healthdata.gov
Homepage URL https://healthdata.gov/d/2fab-r5gs
Program Code 009:033
Source Datajson Identifier True
Source Hash b90ce8a91b07d9df834749f8bb9e06d36547ac0a2e75f3b52adb98be990a5c89
Source Schema Version 1.1

Didn't find what you're looking for? Suggest a dataset here.